Results 141 to 150 of about 3,505 (170)
Some of the next articles are maybe not open access.
Neurogenic detrusor overactivity: an update on management options.
Rhode Island medical journal (2013), 2015Neurogenic detrusor overactivity (NDO) affects a variety of patients with storage and voiding dysfunction including those with multiple sclerosis, spinal cord injuries, Parkinson's disease, cerebral palsy, and myelomeningocele, and includes symptoms of urinary frequency, urgency, and incontinence. Primary treatment goals are 1) preventing renal injury,
Pamela, Ellsworth, Eugene B, Cone
openaire +1 more source
Pathophysiology of neurogenic detrusor overactivity
2015Alexandra McPencow, Toby C. Chai
openaire +1 more source
Onabotulinumtoxin A in the management of neurogenic detrusor overactivity
European Urology Supplements, 2019R. Borcaias +3 more
openaire +1 more source
Botulinum Toxin Treatment of Neurogenic Detrusor Overactivity and Overactive Bladder
2023David Ginsberg +2 more
openaire +1 more source
The effect of GABApentin on neurogenic detrusor overactivity, a pilot study
European Urology Supplements, 2003CARBONE, Antonio +5 more
openaire +2 more sources
OnabotulinumtoxinA Improves Urodynamic Outcomes in Patients With Neurogenic Detrusor Overactivity
Neurourology and Urodynamics, 2013Wayne Lam, Christopher R Chapple
exaly

